Polymer Factory today announces the entering of an OEM agreement with Bruker Daltonics GmbH and Co. KG the global supplier of the MALDI Biotyper microbial identification system. Polymer Factory will provide products from its SpheriCal® platform for use as internal MALDI MS standards in the analysis of antimicrobial resistance.
As of 18 August 2021, Polymer Factory has entered an OEM relationship with Bruker regarding products from the company’s SpheriCal® MALDI MS calibrant platform. The supply of the SpheriCal® products will enable Bruker to provide state-of-the-art solutions for use in antimicrobial resistance. The agreement is not time limited and may be expanded to include additional arrays of SpheriCal® products in the future to match the OEMs development of additional innovative and efficient analytical kits.
Polymer Factory CEO Elin Mignérus:
“We are happy to announce this agreement with Bruker who is a global leader in the mass spectrometry industry. The application of our SpheriCal® products in Bruker’s MALDI Biotyper-based antibiotic susceptability testing portfolio is just one example of the diversity and applicability of our cutting-edge calibrant platform. We look forward to a fruitful and long-lasting relationship with Bruker.”
Bruker Daltonics Global Product Manager IR Biotyper, PCR Kits and CARE consumables Dr. Markus Meyer:
“Latest expansion of research capabilities of the market leading MALDI Biotyper® (MBT) systems (with the MBT sirius as the current innovation) towards fast antimicrobial susceptibility testing (AST) requires the implementation of new MALDI-TOF standards and calibrants. The high quality calibrants in Polymer Factory’s Spherical products are a very good fit for Bruker’s upcoming AST solutions. Especially regarding performance, precision, safety, and future regulations MALDI-TOF based AST testing will be based on assay standardization, which put innovative solutions for calibrants and standards in a central position of assay development. Hence, the Spherical products can play an important role in our assay development process.”
This disclosure contains information that Polymer Factory is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 18 August 2021.
For more information, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com
Find the full press release HERE:
Comments